Skip to content
MarketScale
‹ Back to IndustriesSciences

Why We Show Up for Care

Episode 4 of The Future of Patient Monitoring takes a step back from infrastructure and innovation to explore something deeper: the people behind the technology—and what they’ve learned through years of building smarter systems. Part of the Health and Life Sciences at the Edge podcast series, this conversation is led by Intel’s Kaeli Tully,…

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Michelle Dawn Mooney · Clinician WorkflowHealthcare DataHealthcare InnovationHospital Infrastructure
Share

Key takeaways

01

Episode 4 of The Future of Patient Monitoring takes a step back from infrastructure and innovation to explore something deeper: the people behind the technology—and what they’ve learned through years of building smarter systems.

02

Part of the Health and Life Sciences at the Edge podcast series, this conversation is led by Intel’s Kaeli Tully,…

Get featured

Want to get featured in MarketScale Sciences?

Create a free MarketScale workspace and get your company's expertise featured across our Sciences coverage. No credit card, no demo required.

Start free

Episode 4 of The Future of Patient Monitoring takes a step back from infrastructure and innovation to explore something deeper: the people behind the technology—and what they’ve learned through years of building smarter systems. Part of the Health and Life Sciences at the Edge podcast series, this conversation is led by Intel’s Kaeli Tully, who’s joined by Dr. Sanjay Subramanian, Critical Care Physician and CEO/Founder of Omnicure, Bikram Day, Director of Informatics at Medical Informatics Corp., and Andrew Lamkin, Health and Life Sciences Solutions Architect at Intel.

Each guest brings a unique origin story to the space. “As they say, this is that intersection of what’s great to do and what’s wanted by society,” says Day, who’s been connecting devices since childhood. Subramanian emphasizes the clinician’s lens, noting, “There’s always a need to make technology work best for clinicians… not all have the bandwidth or training to take that leap, but it’s impactful if you do.” Lamkin adds, “Healthcare is so much more challenging in so many ways than aerospace. It’s such a tough environment to introduce technology into thoughtfully.”

The episode also dives into standout projects, like the National Emergency Critical Care Network (NET-CCN), which connected patients to critical care physicians nationwide during COVID-19 using only smartphones. From early EMR integrations to scalable AI applications, each guest shares what they’ve learned about moving from data to decisions.

Interoperability, modularity, infrastructure planning—all those things pay long-term dividends,” says Lamkin. Meanwhile, Day looks to what’s next: “If we can store and correlate data, those insights become valuable. AI can literally build the chain of events and causality.”

Ultimately, the conversation is a powerful reminder that healthcare innovation is a human journey—and the smartest systems are the ones designed to support real people, every step of the way.

Connect with the thought leaders driving this discussion:

Subscribe to this channel on Apple Podcasts and Spotify to hear more from the Intel Internet of Things Group.

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Get your team featuredSee how it works15 minutes, straight to a calendar.

About the author

MD

Michelle Dawn Mooney is a media professional and host known for her work in broadcast journalism and B2B content.

Follow Sciences Insights

Get new expert content in your inbox.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Sciences Insights

Resilience and Lilly Invest $750 Million to Increase U.S.-Manufactured Medicine Supply

Resilience and Lilly Invest $750 Million to Increase U.S.-Manufactured Medicine Supply

Resilience and Eli Lilly are investing $750 million to expand KwikPen injectable device production at Resilience's Cincinnati-region manufacturing facility, expected to create 400 high-skilled jobs and reach full operations by early 2027. The partnership builds on their collaboration since 2023, which has already produced over 150 million doses of Lilly medications for the U.S. market.

  • 01$750 million investment to expand Resilience's Ohio manufacturing capacity for Eli Lilly's KwikPen injectable device production
  • 02400 new high-skilled jobs expected in Cincinnati region, with full operations by early 2027
  • 03Partnership has already produced over 150 million doses of Lilly medications for the U.S. market since 2023

Sep 14, 2026

ENEOS ran an AI controller on a distillation column for 35 days and cut steam use 40%

ENEOS ran an AI controller on a distillation column for 35 days and cut steam use 40%

ENEOS Materials and Yokogawa ran an autonomous AI controller on a butadiene distillation column for 35 days and cut steam use 40%. It’s a real operations proof point. It also puts integration and governance gaps front and center.

  • 01A 35-day closed-loop run is a stronger autonomy proof point than a demo, it forces plants to prove handover, fallback, and KPIs over real feed and operating swings.
  • 02Steam reduction claims are compelling, but procurement and ops teams should pin vendors to baselines, operating envelopes, and how off-spec avoidance is measured.
  • 03Agentic AI is showing up as “work management” and “shift checklist” agents before it replaces control engineers, which shifts requirements toward clean, permissioned data access.

Sep 13, 2026

Novaspace sees 6,500+ Earth observation satellites by 2035, and value shifts to payload integration

Novaspace sees 6,500+ Earth observation satellites by 2035, and value shifts to payload integration

Novaspace forecasts more than 6,500 Earth observation satellites launching by 2035. It also projects $155.9 billion in manufacturing revenue, based on a SpaceNews-posted release dated Aug. 21, 2026. As defense-led demand shifts toward revisit rate and persistence, payload integration and fleet interoperability become the hard parts.

  • 01$155.9 billion is tied specifically to satellite manufacturing, not launch or ground, which should reshape how teams size supplier commitments and make-buy decisions.
  • 02Novaspace’s “skyscraper model” framing implies procurement power is shifting to payload integration, test capacity, and software-defined operations, even as the bus becomes more standardized.

Sep 13, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

MD
Michelle Dawn Mooney

Michelle Dawn Mooney is a media professional and host known for her work in broadcast journalism and B2B content.

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512